Suppr超能文献

一个三代家族性骨斑点症患者中新型LEMD3 Y871X突变的鉴定及文献复习

Identification of a novel LEMD3 Y871X mutation in a three-generation family with osteopoikilosis and review of the literature.

作者信息

Zhang Q, Mo Z H, Dong C S, Yang F, Xie Y H, Jin P

机构信息

Department of Endocrinology, 3nd Xiangya Hospital, Central South University, Tongzipo Road, Changsha, 410007, Hunan Province, People's Republic of China.

Department of Anesthesia, The Affiliated Tumor Hospital of Xiangya Medical School of Central South University, Changsha, 410007, Hunan Province, People's Republic of China.

出版信息

J Endocrinol Invest. 2016 Jun;39(6):679-85. doi: 10.1007/s40618-015-0419-z. Epub 2015 Dec 22.

Abstract

INTRODUCTION

Osteopoikilosis is a rare and benign autosomal dominant genetic disorder, characterized by a symmetric but unequal distribution of multiple hyperostotic areas in different parts of the skeleton. Recent studies have reported loss-of-function mutations in the LEM domain containing 3 (LEMD3) gene, encoding an inner nuclear membrane protein, as a cause of osteopoikilosis.

METHODS

We investigated LEMD3 gene in a three-generation family from China, with six patients affected with osteopoikilosis. Peripheral blood samples were collected from family members and 100 healthy controls. All exons of the LEMD3 gene and adjacent exon-intron sequences were amplified by PCR and subsequently sequenced.

RESULTS

A novel heterozygous c.2612_2613insA (p.Y871X) mutation in exon 13 of LEMD3 was identified, which resulted in a frame shift predicted to generate a premature stop codon at amino acid position 871. The mutation co-segregates with the osteopoikilosis phenotype and was not found in 100 ethnically matched controls.

CONCLUSION

We identified a new mutation in LEMD3 gene, accounting for the familial case of osteopoikilosis. In addition we also review the clinical manifestation, diagnosis and treatment of osteopoikilosis.

摘要

引言

骨斑点症是一种罕见的常染色体显性良性遗传病,其特征是骨骼不同部位出现多个骨质增生区域,分布对称但不均匀。最近的研究报告称,编码内核膜蛋白的含LEM结构域3(LEMD3)基因的功能缺失突变是骨斑点症的病因。

方法

我们对一个来自中国的三代家族进行了LEMD3基因研究,该家族中有6名患者患有骨斑点症。采集了家族成员和100名健康对照者的外周血样本。通过聚合酶链反应(PCR)扩增LEMD3基因的所有外显子及相邻的外显子-内含子序列,随后进行测序。

结果

在LEMD3基因第13外显子中鉴定出一个新的杂合c.2612_2613insA(p.Y871X)突变,该突变导致移码,预计在第871位氨基酸处产生一个提前终止密码子。该突变与骨斑点症表型共分离,在100名种族匹配的对照者中未发现。

结论

我们在LEMD3基因中鉴定出一个新突变,该突变解释了该家族性骨斑点症病例。此外,我们还综述了骨斑点症的临床表现、诊断和治疗。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验